Brainstorm Cell Therapeutics Inc. (BCLI) — DEF 14A Filings
All DEF 14A filings from Brainstorm Cell Therapeutics Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Brainstorm Cell Therapeutics Proxy Statement Filed
— May 16, 2025 Risk: medium
Brainstorm Cell Therapeutics Inc. filed its definitive proxy statement on May 16, 2025, for its annual meeting on June 25, 2025. The company, formerly known as -
Brainstorm Cell Therapeutics Files Definitive Proxy Statement
— Aug 16, 2024 Risk: medium
Brainstorm Cell Therapeutics Inc. filed its definitive proxy statement on August 16, 2024, for its annual meeting of stockholders. The filing provides details r
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX